Stellarex Drug-Coated 0.035" Angioplasty Balloon

The Clear DCB Choice

Featuring EnduraCoat Technology

Learn More +

Top-tier outcomes with the lowest therapeutic drug dose in all patients—common to complex

0.014″ DCB is not approved for distribution, sale or use in the USA.
Availability of this product may vary by country.

Choose Efficacy

Stellarex has the highest patency rate of any DCB in a randomized controlled trial—with up to 43% less drug—and the only commercially available DCB with two reported pivotal RCTs.

The Stellarex Difference

Stellarex’s unique coating composition, EnduraCoat Technology, combines amorphous and small-to-large crystalline paclitaxel with polyethylene glycol (PEG) excipient. The result is efficient drug transfer, effective tissue residency, high coating durability and minimal particulate loss.

about the coating +

Choose Safety

Particulate loss is associated with an increased risk of downstream embolization. In bench tests, Stellarex demonstrated 79% less particulate loss than In.Pact.9

compare particulate +
Stellarex DCB Ballon

See more Stellarex clinical evidence

download brochure +